Tobias Klatte
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment 150
- Prostate Cancer Diagnosis and Treatment 23
- Prostate Cancer Treatment and Research 23
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 33
- Oncology top 1%
- Urology top 1%
- Urological Disorders and Treatments 20
- Surgery top 1%
- Bladder and Urothelial Cancer Treatments 114
- Urinary and Genital Oncology Studies 43
-
- Renal and related cancers 84
- Co-authors
- Allan J. PantuckArie S. BelldegrunMichela de MartinoShahrokh F. ShariatFairooz F. KabbinavarMesut RemziMatthias WaldertGrant D. Stewart
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Tobias Klatte
273 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Pulmonary and Respiratory Medicine 5.8k
- Cancer Research 2.0k
- Oncology 2.1k
- Urology 383
- Surgery 2.6k
Countries citing papers authored by Tobias Klatte
This map shows the geographic impact of Tobias Klatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Klatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Klatte more than expected).
Fields of papers citing papers by Tobias Klatte
This network shows the impact of papers produced by Tobias Klatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Klatte. The network helps show where Tobias Klatte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tobias Klatte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 21 | |
| 7 | 2018 | 4 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 4 | |
| 10 | 2017 | 25 | |
| 11 | 2015 | 24 | |
| 12 | 2014 | 20 | |
| 13 | 2012 | 38 | |
| 14 | 2009 | 151 | |
| 15 | 2008 | 15 | |
| 16 | 2008 | 25 | |
| 17 | 2008 | 45 | |
| 18 | 2008 | 9 | |
| 19 | 2008 | 118 | |
| 20 | 2006 | 4 |
About Tobias Klatte
Tobias Klatte is a scholar working on Pulmonary and Respiratory Medicine, Urology and Cancer Research, having authored 277 papers that have together received 8.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (150 papers), Bladder and Urothelial Cancer Treatments (114 papers), Renal and related cancers (84 papers), Urinary and Genital Oncology Studies (43 papers), Cancer Genomics and Diagnostics (33 papers), Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (23 papers) and Urological Disorders and Treatments (20 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.8k citations), Cancer Research (2.0k citations) and Oncology (2.1k citations). Tobias Klatte has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Allan J. Pantuck, Arie S. Belldegrun, Michela de Martino, Shahrokh F. Shariat, Fairooz F. Kabbinavar, Mesut Remzi, Matthias Waldert, Grant D. Stewart, Ilaria Lucca and Andrea Haitel. Their work appears in journals such as Nature, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.